Estrogen receptor; LYN kinase (LYN); phosphoinositide 3-kinase (PI3K) BriefCommunication Pages: 1399 - 1399
Cyclin dependent kinase 7 (CDK7); v-myc myelocytomatosis viral related oncogene neuroblastoma derived (MYCN; NMYC) BriefCommunication Pages: 1401 - 1401
Epidermal growth factor receptor 1 (EGFR1; ErbB1; HER1); HER2 (EGFR2; ErbB2; neu); HER3 (EGFR3; ErbB3); VEGF BriefCommunication Pages: 1402 - 1402
Globohexaosylceramide (globo-H); stage-specific embryonic antigen-3 (SSEA-3); SSEA-4 BriefCommunication Pages: 1403 - 1403
c-jun N-terminal kinase (JNK); MAP kinase 1 (MAPK1; ERK-2); MAPK3 (ERK-1) BriefCommunication Pages: 1407 - 1407
Angiopoietin 2 (ANG2; ANGPT2); placental growth factor (PGF; PlGF); tissue inhibitor of metalloproteinases 3 (TIMP3) BriefCommunication Pages: 1408 - 1408
Nanomolar-scale, high throughput chemical synthesis of drug-like molecules BriefCommunication Pages: 1415 - 1415
Extending therapeutic protein half-lives via fusion to affibodies with pH-dependent binding to neonatal Fc receptor BriefCommunication Pages: 1416 - 1416
RNAi against therapeutic targets with short interfering ribonucleic neutrals (siRNNs) BriefCommunication Pages: 1417 - 1417
Tumor-selective delivery of antisense oligomers (antimiRs) against oncogenic microRNAs BriefCommunication Pages: 1418 - 1418
Chromosome 11 open reading frame 30 (C11orf30), calpain small subunit 1 ( CAPNS1 ; CAPN4 ), signal transducer and activator of transcription 6 (STAT6) and ankyrin repeat domain 27 (ANKRD27) as diagnostic markers for eosinophilic esophagitis (EoE) BriefCommunication Pages: 1419 - 1419
MicroRNA let-7c (MIRLET7C; let-7c), miR-99a and miR-125b as prognostic markers of luminal breast cancer BriefCommunication Pages: 1420 - 1420